|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,429.25 INR | -0.94% |
|
+0.80% | +52.60% |
| 15/05 | Hester Biosciences Limited, Q4 2026 Earnings Call, May 15, 2026 | |
| 15/05 | Hester Biosciences' Consolidated Profit Soars in Fiscal Q4; Shares Jump 10% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HESTER BIOSCIENCES LIMITED | Veterinary Drugs | -0.94% | +0.80% | +52.60% | +28.39% | +0.16% | 22Cr |
-
|
-
|
-
|
- Stock Market
- Stocks
- HESTERBIO Stock
- Charts Hester Biosciences Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition